@inproceedings{inproceedings, title  = {{Tumour xenograft regression can be induced by combining the vascular-targeting agent ZD6126 with the VEGF receptor tyrosine kinase inhibitor ZD6474.}},

 url = {{}},

 year = {{2002}},

 month = {{1}},

 author = {{Ryan AJ and Kendrew J and Ogilvie DJ and Hennequin LF and Brave SR and Ashton SE and Calvete JA and Blakey DC and Wedge SR}},

 volume = {{86}},

 journal = {{BRITISH JOURNAL OF CANCER}},

 pages = {{S99-S100}},

 note = {{Accessed on 2024/12/22}}}